BridgeBio Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

MUN:2CL Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
12 May 25	Sell€184,536,360	KKR & Co. Inc.	Company	6,000,000	€30.76
02 May 25	Sell€3,395,227	Wen-Chaun Lo	Individual	100,000	€33.95
02 May 25	Sell€34,843	Maricel Apuli	Individual	1,026	€33.96
05 Mar 25	Sell€183,541,056	KKR & Co. Inc.	Company	6,000,000	€30.59
31 Jan 25	Sell€102,935,077	Viking Global Investors LP	Company	3,065,616	€33.58
13 Sep 24	Sell€134,698,765	KKR & Co. Inc.	Company	5,800,000	€23.22

Insider Trading Volume

Insider Buying: 2CL insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 2CL?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	8,302,884	4.34%
VC/PE Firms	13,260,971	6.94%
Hedge Funds	22,055,375	11.5%
Institutions	147,520,647	77.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 71.13% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
11.6%	Viking Global Investors LP	22,055,375	€642.5m	-12.2%	2.2%
7.85%	The Vanguard Group, Inc.	14,900,145	€434.0m	-1.18%	0.01%
7.03%	BlackRock, Inc.	13,357,481	€389.1m	-2.57%	0.01%
6.98%	KKR & Co. Inc.	13,260,971	€386.3m	-31.2%	2.66%
3.78%	Janus Henderson Group plc	7,171,399	€208.9m	46.1%	0.1%
3.2%	Aisling Capital Management LP	6,068,125	€176.8m	0%	70.06%
3.03%	State Street Global Advisors, Inc.	5,749,619	€167.5m	-7%	0.01%
3.02%	Farallon Capital Management, L.L.C.	5,731,000	€166.9m	36.6%	1.14%
2.53%	Neil Kumar	4,798,447	€139.8m	-22.1%	no data
2.46%	Capital Research and Management Company	4,667,402	€136.0m	32.3%	0.01%
2%	Frazier Life Sciences Management, LP	3,800,457	€110.7m	0%	5.73%
1.84%	Geode Capital Management, LLC	3,502,894	€102.0m	2.49%	0.01%
1.57%	Laurion Capital Management LP	2,978,167	€86.8m	-20.4%	8.87%
1.54%	Citadel Advisors LLC	2,931,033	€85.4m	133%	0.1%
1.48%	UBS Asset Management AG	2,803,460	€81.7m	14.5%	0.01%
1.47%	Deep Track Capital, LP	2,800,000	€81.6m	242%	3.22%
1.41%	AllianceBernstein L.P.	2,684,146	€78.2m	-3.94%	0.03%
1.14%	FMR LLC	2,170,579	€63.2m	34.2%	no data
1.1%	Pictet Asset Management Limited	2,090,268	€60.9m	15.7%	0.05%
1.09%	Invesco Ltd.	2,075,439	€60.5m	135%	0.02%
1.05%	Cormorant Asset Management, LP	2,000,000	€58.3m	25%	5.24%
0.99%	Manulife Asset Management	1,887,763	€55.0m	0.1%	0.05%
0.98%	Emerald Advisers, LLC	1,869,845	€54.5m	-0.31%	1.56%
0.98%	Sequoia Capital Operations LLC	1,860,364	€54.2m	0%	0.4%
0.97%	Ensign Peak Advisors, Inc.	1,850,039	€53.9m	-6.34%	0.11%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/23 16:44
End of Day Share Price	2025/05/07 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BridgeBio Pharma, Inc. is covered by 25 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
George Farmer	BMO Capital Markets Equity Research
Konstantinos Biliouris	BMO Capital Markets Equity Research
Jason Zemansky	BofA Global Research